NO990850L - Katalytisk nukleinsyre og dens medisinske bruk - Google Patents

Katalytisk nukleinsyre og dens medisinske bruk

Info

Publication number
NO990850L
NO990850L NO990850A NO990850A NO990850L NO 990850 L NO990850 L NO 990850L NO 990850 A NO990850 A NO 990850A NO 990850 A NO990850 A NO 990850A NO 990850 L NO990850 L NO 990850L
Authority
NO
Norway
Prior art keywords
nucleic acid
molecules
medical use
catalytic nucleic
factor
Prior art date
Application number
NO990850A
Other languages
English (en)
Norwegian (no)
Other versions
NO990850D0 (no
Inventor
Nathan Asher
Yaron Tikochinski
Andy Ellington
Original Assignee
Intelligene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL119135A external-priority patent/IL119135A/en
Priority claimed from IL12046697A external-priority patent/IL120466A0/xx
Application filed by Intelligene Ltd filed Critical Intelligene Ltd
Publication of NO990850D0 publication Critical patent/NO990850D0/no
Publication of NO990850L publication Critical patent/NO990850L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1048—SELEX
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/124—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes based on group I or II introns
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/337—Ribozyme

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO990850A 1996-08-26 1999-02-23 Katalytisk nukleinsyre og dens medisinske bruk NO990850L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL119135A IL119135A (en) 1996-08-26 1996-08-26 Catalytic nucleic acid molecules
IL12046697A IL120466A0 (en) 1997-03-17 1997-03-17 In vitro evolution of oligonucleotides
PCT/IL1997/000282 WO1998008974A2 (en) 1996-08-26 1997-08-26 Catalytic nucleic acid and its medical use

Publications (2)

Publication Number Publication Date
NO990850D0 NO990850D0 (no) 1999-02-23
NO990850L true NO990850L (no) 1999-04-23

Family

ID=26323298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990850A NO990850L (no) 1996-08-26 1999-02-23 Katalytisk nukleinsyre og dens medisinske bruk

Country Status (11)

Country Link
US (1) US6387617B1 (de)
EP (2) EP0922114B1 (de)
JP (1) JP2000517181A (de)
CN (1) CN1232509A (de)
AT (2) ATE253128T1 (de)
AU (1) AU717736B2 (de)
CA (1) CA2264246A1 (de)
DE (2) DE69735684T2 (de)
NO (1) NO990850L (de)
NZ (1) NZ334492A (de)
WO (1) WO1998008974A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998027104A1 (en) 1996-12-19 1998-06-25 Yale University Bioreactive allosteric polynucleotides
IL120714A0 (en) * 1997-04-21 1997-08-14 Intelligene Ltd Continuous in vitro evolution of oligonucleotides
EP1019429A4 (de) * 1997-08-20 2001-08-08 Somagenics Inc Antisense- und antigen-therapeutika mit verbesserten bindungseigenschaften und methoden zu ihrer anwendung
IL126732A0 (en) * 1998-10-23 1999-08-17 Intelligene Ltd Pro drug
AU6522599A (en) * 1998-10-23 2000-05-15 Children's Medical Center Corporation Use of a self-cleaving rna motif to modulate gene expression
IL126731A0 (en) * 1998-10-23 1999-08-17 Intelligene Ltd A method of detection
IL130606A0 (en) * 1999-06-23 2000-06-01 Intelligene Ltd An array of nucleic acid sequence
US6506887B1 (en) 1999-07-29 2003-01-14 Somalogic, Incorporated Conditional-selex
IL132710A0 (en) * 1999-11-02 2001-03-19 Intelligene Ltd Catalytic nucleic acid sequences
WO2001064956A2 (en) * 2000-03-01 2001-09-07 Amgen Inc. The identification and use of effectors and allosteric molecules for the alteration of gene expression
US20030104520A1 (en) * 2000-06-15 2003-06-05 Ellington Andrew D. Regulatable, catalytically active nucleic acids
AU2001266917A1 (en) * 2000-06-15 2001-12-24 Board Of Regents Allosterically regulated ribozymes
US6706474B1 (en) * 2000-06-27 2004-03-16 Board Of Trustees Of The University Of Illinois Nucleic acid enzyme biosensors for ions
US7125660B2 (en) 2000-09-13 2006-10-24 Archemix Corp. Nucleic acid sensor molecules and methods of using same
US20030219422A1 (en) * 2001-11-15 2003-11-27 Noxxon Pharma Ag Allosteric ribozymes and uses thereof
US6890719B2 (en) * 2002-05-10 2005-05-10 The Board Of Trustess Of The University Of Illinois Fluorescence based biosensor
ATE516366T1 (de) 2002-07-25 2011-07-15 Archemix Corp Regulierte aptamer-therapeutika
US8853376B2 (en) 2002-11-21 2014-10-07 Archemix Llc Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
US8039443B2 (en) 2002-11-21 2011-10-18 Archemix Corporation Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
US10100316B2 (en) 2002-11-21 2018-10-16 Archemix Llc Aptamers comprising CPG motifs
US7785782B2 (en) * 2002-12-12 2010-08-31 Novartis Vaccines And Diagnostics, Inc. Device and method for in-line blood testing using biochips
US7309589B2 (en) 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
US7892734B2 (en) * 2005-08-11 2011-02-22 The Board Of Trustees Of The University Of Illinois Aptamer based colorimetric sensor systems
US7799554B2 (en) * 2006-03-16 2010-09-21 The Board Of Trustees Of The University Of Illinois Lateral flow devices
US8415461B2 (en) * 2007-01-19 2013-04-09 The Board Of Trustees Of The University Of Illinois Amphiphilic substances and functionalized lipid vesicles including the same
US20080207885A1 (en) * 2007-02-23 2008-08-28 Silverman Scott K Method for site-specific labeling of RNA using a deoxyribozyme
US8058415B2 (en) * 2007-04-24 2011-11-15 The Board Of Trustees Of The University Of Illinois Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes
WO2009012309A2 (en) * 2007-07-16 2009-01-22 The Board Of Trustees Of The University Of Illinois Nucleic acid based fluorescent sensor for divalent copper ion detection
US8568690B2 (en) * 2007-07-31 2013-10-29 The Board Of Trustees Of The University Of Illinois MRI contrast agents and high-throughput screening by MRI
US8367416B2 (en) 2007-08-10 2013-02-05 The Board Of Trustees Of The University Of Illinois Nucleic acid based fluorescent sensor for mercury detection
US20100105039A1 (en) * 2008-06-03 2010-04-29 Yi Lu Label-free colorimetric detection
US8062893B2 (en) 2008-10-10 2011-11-22 The Board Of Trustees Of The University Of Illinois Fluorescent sensor for mercury
US20100305197A1 (en) * 2009-02-05 2010-12-02 Massachusetts Institute Of Technology Conditionally Active Ribozymes And Uses Thereof
US8815156B2 (en) 2010-07-19 2014-08-26 Andalyze, Inc. Sensor housing and reagent chemistry
AU2012340086A1 (en) * 2011-11-17 2014-05-29 The Regents Of The University Of California Therapeutic RNA switches compositions and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3276955B2 (ja) 1988-09-30 2002-04-22 ジーン−トラック・システムス Ｒｎａの鋳型の末端に結合したプローブ構造およびその使用方法
WO1994013791A1 (en) 1992-12-04 1994-06-23 Innovir Laboratories, Inc. Regulatable nucleic acid therapeutic and methods of use thereof
ATE217347T1 (de) * 1992-12-04 2002-05-15 Univ Yale Diagnose mittels signalverstärkung durch ein ribozym
US5807718A (en) * 1994-12-02 1998-09-15 The Scripps Research Institute Enzymatic DNA molecules
DE69532525T2 (de) 1995-02-03 2007-02-08 Denso Corp., Kariya Filter
MX9706501A (es) * 1995-02-27 1998-02-28 Intelligene Ltd Deteccion de biomoleculas.

Also Published As

Publication number Publication date
WO1998008974A2 (en) 1998-03-05
NO990850D0 (no) 1999-02-23
JP2000517181A (ja) 2000-12-26
US6387617B1 (en) 2002-05-14
DE69725861T2 (de) 2004-08-19
EP1350854B1 (de) 2006-04-12
ATE253128T1 (de) 2003-11-15
EP0922114A2 (de) 1999-06-16
NZ334492A (en) 2000-09-29
DE69725861D1 (de) 2003-12-04
EP0922114B1 (de) 2003-10-29
ATE323180T1 (de) 2006-04-15
CA2264246A1 (en) 1998-03-05
AU3862097A (en) 1998-03-19
AU717736B2 (en) 2000-03-30
EP1350854A1 (de) 2003-10-08
DE69735684D1 (de) 2006-05-24
WO1998008974A3 (en) 1998-07-02
CN1232509A (zh) 1999-10-20
DE69735684T2 (de) 2007-04-05

Similar Documents

Publication Publication Date Title
NO990850L (no) Katalytisk nukleinsyre og dens medisinske bruk
DK1100880T3 (da) Urat oxidase
DE69730820D1 (de) Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
ES2085245T3 (es) Procedimiento de purificacion de acidos nucleicos.
NZ289720A (en) Nucleic acids coding for a telomerase, a ribonucleoprotein enzyme involved in telomere synthesis
HUP9900018A1 (hu) Cirkuláris DNS-molekula feltételes replikációs origóval, eljárás előállítására és génterápiában való felhasználására
DE69637256D1 (de) Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
IT8721618A0 (it) Prodecimento per la depurazione bilogica di acque reflue.
DE3854950D1 (de) Vascular-antikoagulierende Proteine, DNA die diese kodieren, Verfahren zu deren Herstellung sowie deren Verwendung
DK0713495T3 (da) Fremgangsmåder til forstærkning af den biologiske aktivitet af chemokiner
IL154298A0 (en) Papap proteins, their preparation and use
ATE291586T1 (de) Humanes antibiotisches protein
BR0000698A (pt) 15, 15'-dioxigenases de beta, beta-caroteno
ES2085403T3 (es) Gen de origen microbiano para peroxidasa.
ATE309371T1 (de) Protein mit dnase-aktivität
WO2003060092A3 (en) Modified fatty acid hydroxylase protein and genes
ATE528392T1 (de) Neues protein und dessen dns
DE69521281D1 (de) Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA.
ATE319826T1 (de) Minimale promotoren und ihre verwendung
DE60025036D1 (de) Verfahren zur züchtung von haftenden tierischen zellen
DE3887376D1 (de) 2-Methyl-4-amino-5-aminomethylpyrimidinkarbonat, Verfahren zu dessen Herstellung und diese brauchende Methode zur Reinigung von 2-Methyl-4-amino-5-aminomethylpyrimidin.
MX9709596A (es) Adn catal ??tico.
WO2002088345A3 (en) Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application